Sou Hu Cai Jing·2025-10-13 19:28Group 1 - The core point of the news is that southbound funds have been reducing their holdings in Fosun Pharma (02196.HK), with a total net reduction of 911.55 million shares over the last five trading days and 2,214.17 million shares over the last twenty trading days [1][2] - As of October 13, 2025, southbound funds hold 310 million shares of Fosun Pharma, accounting for 56.07% of the company's total issued ordinary shares [1][2] - The trading data indicates fluctuations in shareholding, with a decrease of 119.3 million shares on October 13, 2025, representing a change of -0.38% [2] Group 2 - Fosun Pharma operates in five segments: pharmaceutical, medical devices and diagnostics, healthcare services, pharmaceutical distribution and retail, and other pharmaceutical-related businesses [2] - The pharmaceutical segment focuses on innovative drugs, mature pharmaceutical products, and vaccines, while the medical devices segment includes molecular diagnostics and medical beauty devices [2] - The company's products primarily target treatment areas such as oncology, immunology, and central nervous system disorders [2]